BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12558906)

  • 21. Preferential association of hepatitis C virus with CD19
    Wang RY; Bare P; De Giorgi V; Matsuura K; Salam KA; Grandinetti T; Schechterly C; Alter HJ
    Hepatology; 2016 Dec; 64(6):1900-1910. PubMed ID: 27641977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of candidate virus receptors in human T lymphocytes prone or resistant to infection with patient-derived hepatitis C virus.
    Sarhan MA; Chen AY; Michalak TI
    PLoS One; 2013; 8(4):e62159. PubMed ID: 23626783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
    Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
    Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
    Mizorogi F; Hiramoto J; Nozato A; Takekuma Y; Nagayama K; Tanaka T; Takagi K
    Intern Med; 2000 Feb; 39(2):112-7. PubMed ID: 10732826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses.
    Comarmond C; Lorin V; Marques C; Maciejewski-Duval A; Joher N; Planchais C; Touzot M; Biard L; Hieu T; Quiniou V; Desbois AC; Rosenzwajg M; Klatzmann D; Cacoub P; Mouquet H; Saadoun D
    J Hepatol; 2019 Nov; 71(5):908-919. PubMed ID: 31279905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic hypermutation and mRNA expression levels of the BCL-6 gene in patients with hepatitis C virus-associated lymphoproliferative diseases.
    Hofmann WP; Fernandez B; Herrmann E; Welsch C; Mihm U; Kronenberger B; Feldmann G; Spengler U; Zeuzem S; Sarrazin C
    J Viral Hepat; 2007 Jul; 14(7):484-91. PubMed ID: 17576390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD81
    Ashraf Malik M; Ishtiyaq Ali Mirza J; Umar M; Manzoor S
    Viral Immunol; 2019 Dec; 32(10):453-462. PubMed ID: 31755827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of CD81 expression on lymphocyte subsets during interferon-alpha-based antiviral treatment of patients with chronic hepatitis C.
    Kronenberger B; Herrmann E; Hofmann WP; Wedemeyer H; Sester M; Mihm U; Ghaliai T; Zeuzem S; Sarrazin C
    J Leukoc Biol; 2006 Aug; 80(2):298-308. PubMed ID: 16735696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
    Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
    Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD21(-/low) marginal zone B cells highly express Fc receptor-like 5 protein and are killed by anti-Fc receptor-like 5 immunotoxins in hepatitis C virus-associated mixed cryoglobulinemia vasculitis.
    Terrier B; Nagata S; Ise T; Rosenzwajg M; Pastan I; Klatzmann D; Saadoun D; Cacoub P
    Arthritis Rheumatol; 2014 Feb; 66(2):433-43. PubMed ID: 24504816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD81 expression for discrimination between sustained virologic response and relapse in patients with chronic hepatitis C.
    Welker MW; Hofmann WP; Lange CM; Herrmann E; Sarrazin C; Zeuzem S; Kronenberger B
    Scand J Gastroenterol; 2011 Jul; 46(7-8):973-80. PubMed ID: 21615225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients.
    Ni J; Hembrador E; Di Bisceglie AM; Jacobson IM; Talal AH; Butera D; Rice CM; Chambers TJ; Dustin LB
    J Immunol; 2003 Mar; 170(6):3429-39. PubMed ID: 12626604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia.
    Fognani E; Giannini C; Piluso A; Gragnani L; Monti M; Caini P; Ranieri J; Urraro T; Triboli E; Laffi G; Zignego AL
    PLoS One; 2013; 8(5):e62965. PubMed ID: 23650540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of occult low-grade b-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia.
    Rasul I; Shepherd FA; Kamel-Reid S; Krajden M; Pantalony D; Heathcote EJ
    Hepatology; 1999 Feb; 29(2):543-7. PubMed ID: 9918933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
    Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
    Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association.
    Musto P
    Clin Lymphoma; 2002 Dec; 3(3):150-60. PubMed ID: 12521391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
    Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
    Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
    Terrier B; Chaara W; Dufat L; Geri G; Rosenzwajg M; Musset L; Sène D; Saadoun D; Six A; Klatzmann D; Cacoub P
    Autoimmun Rev; 2014 Mar; 13(3):319-26. PubMed ID: 24220267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders.
    Gulli F; Basile U; Gragnani L; Fognani E; Napodano C; Colacicco L; Miele L; De Matthaeis N; Cattani P; Zignego AL; Rapaccini GL
    Dig Liver Dis; 2016 Aug; 48(8):927-33. PubMed ID: 27289333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.